Robert Hendren, DO
Working Title
Professor
Robert L. Hendren, D.O., is Professor of Psychiatry and Behavioral Science Emeritus 2023; Division of Child and Adolescent Psychiatry; Co-Director of the UCSF Dyslexia Center 2013-2023; and Director, Program for Research on Neurodevelopmental, Translational Outcomes (PRONTO) http://hendrenlab.ucsf.edu 2011-2023. He works in the Center for Autism Spectrum Disorders and Neurodevelopmental Disorders Program. Dr. Hendren is Past President of the American Academy of Child and Adolescent Psychiatry (2007-2009). He has published well over 150 scientific papers and 5 books and has been listed in “The Best Doctors in America”, each year since it was first published in 1996. He is currently completing a book, "Listen to Your Hum: An Examined Spirituality."
Dr. Hendren took his residency in general psychiatry at the Mayo Graduate School of Medicine, and his child and adolescent psychiatry fellowship at the Yale Child Study Center. He is board certified in General as well as Child and Adolescent Psychiatry. He has been on the faculty at the George Washington University School of Medicine, the University of New Mexico School of Medicine, and the University of Medicine and Dentistry of New Jersey (now Rutger’s) - Robert Wood Johnson and New Jersey Medical Schools. From 2001-2009, he was Professor of Psychiatry and Executive Director and Tsakopoulos-Vismara Chair at the University of California, Davis M.I.N.D. Institute (Medical Investigation of Neurodevelopmental Disorders).
His areas of research and publication interests are translational interventional outcomes research including clinical pharmacology, nutraceutical and nutritional trials using biomarkers (MRI, measures of inflammation, oxidative stress, immune function, pharmacogenomics and metabolomics) to enhance resilience in neurodevelopmental disorders. He is currently applying a targeted outcomes research approach in collaborative projects with the Oak Hill School for youth with severe autism and neurodevelopmental spectrum disorders in San Anselmo, CA where he is also Chairman of the Board. He has been on the Board of the Autism Research Institute since 2017.
Dr. Hendren took his residency in general psychiatry at the Mayo Graduate School of Medicine, and his child and adolescent psychiatry fellowship at the Yale Child Study Center. He is board certified in General as well as Child and Adolescent Psychiatry. He has been on the faculty at the George Washington University School of Medicine, the University of New Mexico School of Medicine, and the University of Medicine and Dentistry of New Jersey (now Rutger’s) - Robert Wood Johnson and New Jersey Medical Schools. From 2001-2009, he was Professor of Psychiatry and Executive Director and Tsakopoulos-Vismara Chair at the University of California, Davis M.I.N.D. Institute (Medical Investigation of Neurodevelopmental Disorders).
His areas of research and publication interests are translational interventional outcomes research including clinical pharmacology, nutraceutical and nutritional trials using biomarkers (MRI, measures of inflammation, oxidative stress, immune function, pharmacogenomics and metabolomics) to enhance resilience in neurodevelopmental disorders. He is currently applying a targeted outcomes research approach in collaborative projects with the Oak Hill School for youth with severe autism and neurodevelopmental spectrum disorders in San Anselmo, CA where he is also Chairman of the Board. He has been on the Board of the Autism Research Institute since 2017.
- 06/1981 - child psychiatry, Yale Child Study Center
- 06/1979 - Psychiatry, Mayo Clinic Graduate School of Medicine
- DO, 06/1975 - medicine, Kirksville College of Osteopathic Medicine
Education, Special
Adolescent Psychiatry
Autistic Disorder
Child Psychiatry
Risperidone
Complementary Therapies
Antipsychotic Agents
Fatty Acids, Omega-3
Vitamin B 12
Antioxidants
Attention Deficit Disorder With Hyperactivity
Academic Performance
Dyslexia
Autism Spectrum Disorder
Child Development Disorders, Pervasive
September 1, 2015 - June 30, 2021 - Understanding literacy acquisition through immersion in foreign languages , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01HD078351
February 1, 2008 - January 31, 2011 - Pharmacogenomics in Autism Treatment , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R21MH080026
April 1, 1991 - March 31, 1995 - NEUROPSYCHOPHYSIOLOGIC STUDY-SEVERELY DISTURBED CHILDREN , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01MH045838
Contact information
1550 Fourth Street, #282
San Francisco, CA 94158
United States